News

PDF Articles

Quest For Answers
"We're trying to understand how cancer cells die, how they're affected by chemotherapy or newer agents, why they become resistant to certain treatments and how to develop strategies to reverse the resistance," says Wafik El-Deiry, MD, PhD, chief of hematology/oncology at Penn State Hershey Medical Center
pdf_icon View the entire .PDF article

Kuwait Prize In Applied Sciences
Dr. El-Deiry was recognized for his work on tumor suppressor genes including p53 and TRAIL, and mechanisms that determine cancer therapeutic response. Dr. El-Deiry was recognized for developing new strategies targeting cell death for cancer therapy.
pdf_icon Read the full article from Cancer Biology & Therapy

Small Molecule Drug Drives Cancer Cells to Suicide
Cancer researchers have pinned down a molecule that can kick-start the body's own tumour-destroying systems, triggering cell death in cancerous but not healthy tissue in mice.
pdf_icon Read the full article from Nature News

Sen. Toomey Visits El-Deiry Lab
Last April, United States Senator Pat Toomey visited Doctor El-Deiry's Lab at Penn State Hershey.
pdf_icon View all the photos from the visit

Laboratory of Translational Oncology and Experimental Cancer Therapeutics
The El-Deiry Lab was established in 1994 and moved to Penn State University to the new Penn State Hershey Cancer Institute....
pdf_icon View all the photos from the visit

Unlocking Genes, Unlocking Savings
The health care industry is on the cusp of using genetic....
pdf_icon View all the photos from the visit

Oncology Nurses Honored for Excellence
To achieve Magnet status, a hospital must undergo a rigorous review process demonstrating they are committed to....
pdf_icon View all the photos from the visit

Penn researchers identify small molecules capable of fighting treatment-resistant tumors
Using a newly developed drug screen, researchers at the University of Pennsylvania School of Medicine have discovered small molecule compounds that are able to perform the functions of a....
pdf_icon Read the full article from Nature News

Cambridge
The major interest of the lab in recent years has been to understand the mechanism of action of the tumor suppressor p53 and the contribution of its downstream target
pdf_icon Read the full article from Nature News

Business Ventures

Oncoceutics (a biopharmaceutical company started by Dr. El-Deiry)
Oncoceutics, Inc. is a drug discovery and development company targeting the most potent suppressor pathways in human cancer.
Oncoceutics
View Web Site

External Profiles

ISI Interview (1998)
View Profile

Interviews

Faculty of 1000
View Profile

WebmedCentral Specialty Editor for Oncology
View Profile